Caricamento...
Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital
BACKGROUND: To study the effect of an ab interno gelatin stent (XEN45 Gel Stent, Allergan Inc., Irvine, California, USA) on intraocular pressure (IOP) as placed by glaucoma fellowship trainees in eyes with refractory glaucoma. METHODS: A prospective noncomparative study at a tertiary training center...
Salvato in:
| Pubblicato in: | Eye Vis (Lond) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995155/ https://ncbi.nlm.nih.gov/pubmed/32021876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40662-019-0171-0 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|